Omic tools applied to elucidation of the role of intestinal microbiota in the remission of Inflammatory Bowel Disease (IBD) based on therapeutic diet

• Grant number: 16/16293-5
• Support Opportunities: Scholarships abroad - Research
• Start date: January 01, 2017
• End date: July 31, 2017
• Field of knowledge: Agronomical Sciences - Food Science and Technology - Food Science
• Principal Investigator: Elaine Cristina Pereira de Martinis
• Grantee: Elaine Cristina Pereira de Martinis
• Host Investigator: Daniel P. Beiting
• Host Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
• Institution abroad: University of Pennsylvania, United States

Abstract

The healthy human gut 'microbiome' constitutes an ecosystem of microbes that play an essential role in maintaining health and the microbiome composition shifts in response to several factors, including diet. For example, during Inflammatory Bowel Disease (IBD) the overall diversity of the microbiome declines and treatment restores diversity. Although laboratory mouse models have been instrumental in identifying mechanisms underlying IBD, mice do not exhibit clinical heterogeneity in IBD symptoms or response to treatment, making them a poor model for this aspect of human disease. We propose to study the microbioma of dogs with canine chronic enteropathy (CCE), a spontaneous inflammatory intestinal disease that recapitulates human disease. The research group of the supervisor abroad (Dr. Beiting at Pennsylvania University) has conducted a trial with dogs that entered in remission of CCE after therapeutic diet and, the main goal of this project is to analyze fecal samples of the animals before and after treatment, to identify possible changes in the intestinal microbiome and also, changes in the metabolites in body fluids (metabolomics). We postulate that the analysis of the microbiome following treatment in both responding and non-responding individuals will allow for the identification of "protective" bacteria or "opportunistic" bacteria that drive disease progression. While such studies would be challenging and expensive to carry out in humans, they are relatively inexpensive and can be rigorously controlled in dogs, providing important insight into the role of the microbiome in IBD. This proposal is both technically and conceptually innovative, since it applies cutting-edge metagenomics to study an animal model of spontaneous IBD during treatment-induced remission. The involvement of a mentoring team with expertise in human IBD enhances the translational potential of the work, and it is an aspect of that would only be possible at an institution like the UPenn, where a world-leading veterinary hospital, adult human hospital and children's hospital are all within a few blocks of each other.For the near future, these studies may contribute for the development of potential probiotics for treatment of IBD.

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

WANG, SHUAI; MARTINS, RENE; SULLIVAN, MEGAN C.; FRIEDMAN, ELLIOT S.; MISIC, ANA M.; EL-FAHMAWI, AYAH; DE MARTINIS, ELAINE CRISTINA PEREIRA; O'BRIEN, KEVIN; CHEN, YING; BRADLEY, CHARLES; et al. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. MICROBIOME, v. 7, n. 1, AUG 31 2019. (16/16293-5)

PEREIRA, MARITA GIMENEZ; DE ALMEIDA, OTAVIO GUILHERME GONCALVES; DA SILVA, HEVELIN REGIANE AUGUSTO; ISHIZAWA, MARILIA HARUMI; DE MARTINIS, ELAINE CRISTINA PEREIRA. Studies on host-foodborne bacteria in intestinal three-dimensional cell culture model indicate possible mechanisms of interaction. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, v. 37, n. 2, FEB 2021. (17/18928-0, 17/13759-6, 16/16293-5)